Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit
NCT03162341 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-04-28
Summary
The objective of this research is to evaluate the correlation between DECT and US explorations performed in a routine clinical setting for the measurement of change in tophus size in gout patients after 24 months of treatment.
Conditions
Interventions
- PROCEDURE
-
ultrasonography
The tophus volume will be assess using ultrasonography.
- PROCEDURE
-
DECT
The tophus volume will be assess using dual-energy computed tomography (DECT).
Sponsors & Collaborators
-
Horizon Pharma Rheumatology LLC
collaborator INDUSTRY -
Lille Catholic University
lead OTHER
Principal Investigators
-
Tristan Pascart, MD · Hospital Group of the Catholic Institute of Lille
-
Sébastien Ottaviani, MD · Bichat Hospital of Paris
-
Pascal Richette, MD PhD · Lariboisiere Hospital of Paris
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-10
- Primary Completion
- 2021-11-08
- Completion
- 2021-11-08
Countries
- France
Study Locations
More Related Trials
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
Sonographic Signs of Gouty Arthritis in a Cohort of Egyptian Patients: a Cross Sectional Multicenter Study
NCT04734093 ·Status: COMPLETED
-
Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout
NCT06956885 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
Gout Self-Monitoring Aiming to Reach Target
NCT03274063 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration
NCT03038386 ·Status: UNKNOWN ·Phase: NA
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
NCT01549210 ·Status: COMPLETED
-
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
NCT01510769 ·Status: COMPLETED ·Phase: PHASE3
-
Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout
NCT04953533 ·Status: UNKNOWN
-
Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
NCT05109936 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
NCT00741442 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Treat-to-target by Email During Urate-lowering Therapy in Gout
NCT04733079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
NCT00675103 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
NCT01112982 ·Status: COMPLETED ·Phase: PHASE4
-
Lesinurad and Febuxostat Combination Extension Study in Gout
NCT01808144 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)
NCT03767322 ·Status: UNKNOWN ·Phase: PHASE2
-
A Exploratory Trial of WTX221 in Refractory Gout Patients
NCT05800041 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Remote Monitoring of Gout Feasibility Study
NCT06211322 ·Status: COMPLETED ·Phase: NA
-
Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions
NCT02903446 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Gout Care After an ED Visit
NCT06534554 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia
NCT03934099 ·Status: COMPLETED ·Phase: PHASE2